November 22nd 2024
With this $3.6 million investment, the CDMO will strengthen its advanced labeling, automated visual inspection, and fill/finish technology.
June 26th 2024
Novo Nordisk plans to invest $4.1 billion in a second fill/finish manufacturing facility in Clayton, N.C., boosting its current 2024 investments into production to $6.8 billion.
March 1st 2024
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
February 15th 2024
The company’s Itasca, Ill., facility will offer chemistry, manufacturing, and controls analytical testing support.
October 2nd 2023
The newly established business under Advent International and Warburg Pincus will be named Simtra BioPharma Solutions.